Biotechnology News

September 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced it was awarded a contract from the U.S. Food and Drug Administration (FDA) to provide the agency with MiSeq sequencing systems and reagents for conducting whole genome...

September 18, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”) (OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that director of business development, Matthew Vincent, Ph.D., will be presenting at...

September 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals today announced that Yuchun Lee joined its board of directors as an independent director. Mr. Lee was appointed to the class of directors whose term expires in 2013.

September 18, 2012

MILAN--(BUSINESS WIRE)--European CE Mark approval for extended indications of Sorin's PERCEVAL S sutureless aortic valve, paving the way for adoption of Minimally Invasive Cardiac Surgery

September 18, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that interim results from the Company’s Phase 2b/3 GALAXY Trial will be presented at the European Society of Medical Oncology 2012 Congress held in...

September 18, 2012

DUBLIN, OHIO--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces Enrollment of First Subject in Phase 2 Trial of NAV4694 as an Aid in Diagnosing Alzheimer’s Disease

September 18, 2012

GREENVILLE, S.C.--(BUSINESS WIRE)--South Carolina Biotechnology Industry Organization (SCBIO) plans "What Next?" annual conference for biotech, health care and life sciences industry.

September 18, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori will give a corporate presentation and participate on a cell therapy panel discussion at the Noble Financial Capital Markets Life Sciences Exposition on September 24.

September 18, 2012

AUSTIN, Texas--(BUSINESS WIRE)--LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced that it has launched a new, global corporate website. The website address (...

September 18, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Cenduit LLC continues to offer an unprecedented level of support for its clients with the appointment of John Cline as its Vice President of Client Services.

September 18, 2012

PORTLAND, Ore. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MolecularMD Corp. and ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that MolecularMD has voluntarily withdrawn its Premarketing Approval (PMA) application to the U.S. Food and...

September 18, 2012

KYOTO, Japan--(BUSINESS WIRE)--AB SCIEX and University of Wollongong collaborate on lipid analysis.

September 18, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm issued US composition of matter patent that provides protection for formulations of inhaled ciprofloxacin until 2031.

September 18, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b8w2pf/modern) has...

September 18, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals to Present at Society for Immunotherapy of Cancer Annual Meeting on October 26 & 27, 2012

September 18, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--The 2012 FDB Customer Seminar, September 19-21, in San Diego, CA will convene drug knowledge experts to share best practices and provide insight in medication decision support for healthcare IT.

September 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today appointed Brian Hess as Interim Chief Science Officer...

September 18, 2012

CINCINNATI--(BUSINESS WIRE)--Radiant Research, Inc. announced today that after only two months of recruitment efforts it has randomized over 1,000 patients into the Light Study, Orexigen's cardiovascular outcomes trial.

September 18, 2012

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--ASCC Initiates Talks with Biotech Company Using NASA Technology in Cosmetics

September 18, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Explores NASA Technology in Stem Cell Search

September 18, 2012

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd., a leader in services for understanding immune responses, announced today the commercial launch of ProStorm™, an in vitro cytokine release assay, which can help assess the likelihood of first...

September 18, 2012

MENLO PARK, Calif. & GRAMBACH/GRAZ, Austria--(BUSINESS WIRE)--DNA2.0, the leading bioengineering solutions provider and VTU Technology, the leader in Pichia pastoris protein expression services, today announced a partnership to develop and...

September 18, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Aprea today announced positive data from a completed Phase I/II clinical study with its investigational drug APR-246. The results from the study have been published in the Journal of Clinical Oncology...

September 17, 2012

PLYMOUTH, Minn.--(BUSINESS WIRE)--Covidien today announced the launch of the Viance™ Crossing Catheter and Enteer™ Re-entry System for treating chronic total occlusions (CTOs) endovascularly.

September 17, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the closing of an underwritten public offering of 3,784,000 shares of its common stock at...

September 17, 2012

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene® platform. Group A...

September 17, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa to attend and participate in one-on-one meetings at UBS Global Life Sciences Conference

September 17, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces Fourth Quarter and Fiscal Year 2012 Release date and Conference Call Information

September 17, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments for major unmet medical needs, today announced that it has closed a $5 million private financing. The financing...

September 17, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: According to the resolution by the General Meeting on 23 May 2011 and 14 August 2012, the Board of Directors in DiaGenic ASA (OSE:DIAG) today allotted options to DiaGenic employees. The share...

September 17, 2012

BETHESDA, Md.--(BUSINESS WIRE)--The 2012 Mid-Atlantic Bio Conference, Sept. 27-28, will give attendees the inside track on how area biotech CEOs found their way to the top during a panel on building value and planning exits.

September 17, 2012

PALO ALTO & SUNNYVALE, Calif.--(BUSINESS WIRE)--Fujitsu Laboratories of America announced a collaboration with the VA Palo Alto Health Care System employing technology to monitor the rehabilitation of veterans suffering from PTSD during...

September 17, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--Strengthens Merck Millipore’s opportunity to offer STEMCCA reprogramming kits for stem cell research

September 17, 2012

SAN ANTONIO--(BUSINESS WIRE)--STTR grant to explore functional enhancement of amniotic fluid-derived stem cells thru fucosylation with ASC-101

September 17, 2012

ST. LOUIS--(BUSINESS WIRE)--Confluence Life Sciences, a biotech company focused on the discovery and development of kinase inhibitors to treat cancer and inflammatory disease, announced a $4M Series A venture capital financing.

September 17, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia AB (STO:BIOG) A double-blind, placebo-controlled study of 80 colicky infants showed that the crying time was significantly reduced among the infants supplemented by drops with the probiotic...

September 17, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT) today announced top-line results from a Phase 2 trial of TC-5619 as a treatment for inattentive-predominant attention deficit/hyperactivity disorder (ADHDi). In the trial, TC-...

September 17, 2012

BETHESDA, Md.--(BUSINESS WIRE)--BrainScope® Company, Inc. has been awarded a contract by the United States Army for development of a “Miniature Field Deployable System For Rapid TBI Assessment," valued at $2.67 million over 2 years.

September 17, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience today announced the publication of results from a clinical study in the AJC suggesting patients with Type 2 diabetes mellitus are at increased risk for CVD-related events.

September 17, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Victor Vinci, Ph.D., has joined Cook Pharmica’s leadership team as vice president and chief scientific officer

September 17, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Aspen Technology, Inc. (NASDAQ: AZPN), a leading provider of software and services to the process industries, has won two Pharmaceutical Manufacturing magazine “Innovations 2012” awards. aspenONE Supply Chain...

September 17, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the UBS Global Life Sciences Conference on Thursday, September 20, at 4:30 p.m. ET. The conference will be held at the...

September 17, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion is pleased to announce that it has been awarded full accreditation by the Association for the Accreditation Human Research Protection Programs (AAHRPP).

September 17, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals received Qualified Infectious Disease Product (QIDP) designation from the FDA for delafloxacin, provided under the new Generating Antibiotic Incentives Now (GAIN) program.

September 17, 2012

FRAMINGHAM, Mass.--(BUSINESS WIRE)--AB SCIEX announces biologics initiative

September 17, 2012

LONDON--(BUSINESS WIRE)--Immune Targeting Systems Limited (“ITS”), an emerging leader in the development of vaccines that promote T-cell responses against viruses and cancers, today announces compelling data from two Phase I clinical trials of...

September 17, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Oncology today announced that important data from its lung cancer and renal cell carcinoma (RCC) portfolios will be presented at the upcoming European Society for Medical Oncology (ESMO) Congress in Vienna,...

September 17, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that it is sponsoring a symposium on Muscle Wasting in Non-Small Cell Lung Cancer Patients at 12:00 pm eastern daylight time on September 22, 2012, at the Hilton Back Bay...

September 17, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals to Host Analyst Meeting September 28th